Evaluation of Voriconazole Pharmacodynamics Using Time-Kill Methodology
暂无分享,去创建一个
Russell E. Lewis | Erika J. Ernst | Michael E. Klepser | M. Klepser | M. Pfaller | E. Ernst | D. Malone | Michael A. Pfaller | Dennis Malone | R. Lewis
[1] M. Klepser,et al. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans. , 1998, The Journal of antimicrobial chemotherapy.
[2] Ronald N. Jones,et al. Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans , 1997, Antimicrobial agents and chemotherapy.
[3] C. Kauffman,et al. In vitro activity of voriconazole against Candida species. , 1998, Diagnostic microbiology and infectious disease.
[4] M. Pfaller,et al. In Vitro Activities of Voriconazole (UK-109,496) and Four Other Antifungal Agents against 394 Clinical Isolates ofCandida spp , 1998, Antimicrobial Agents and Chemotherapy.
[5] R. Pearson,et al. Method of reliable determination of minimal lethal antibiotic concentrations , 1980, Antimicrobial Agents and Chemotherapy.
[6] M. Ghannoum,et al. Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida species , 1997, Antimicrobial agents and chemotherapy.
[7] M. Ghannoum,et al. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Labora , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] R. Haubrich,et al. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] Russell E. Lewis,et al. Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods , 1998, Antimicrobial Agents and Chemotherapy.
[10] Michael H. Miller,et al. Pharmacodynamics of Fluconazole in a Murine Model of Systemic Candidiasis , 1998, Antimicrobial Agents and Chemotherapy.
[11] D. Andes,et al. Characterization and Quantitation of the Pharmacodynamics of Fluconazole in a Neutropenic Murine Disseminated Candidiasis Infection Model , 1999, Antimicrobial Agents and Chemotherapy.